BNP Paribas Asset Management Holding S.A. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 39 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP Paribas Asset Management Holding S.A. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,991
+2.4%
2,000,0000.0%0.01%0.0%
Q4 2022$1,944
-99.9%
2,000,0000.0%0.01%
-12.5%
Q3 2022$1,940,000
-0.3%
2,000,0000.0%0.01%
+14.3%
Q2 2022$1,946,000
-0.5%
2,000,0000.0%0.01%0.0%
Q1 2022$1,955,000
-2.5%
2,000,0000.0%0.01%0.0%
Q4 2021$2,006,000
+0.5%
2,000,0000.0%0.01%0.0%
Q3 2021$1,997,000
+1.2%
2,000,0000.0%0.01%0.0%
Q2 2021$1,973,000
-4.1%
2,000,0000.0%0.01%
-12.5%
Q1 2021$2,057,000
+8.7%
2,000,0000.0%0.01%
-11.1%
Q4 2020$1,893,000
+3.8%
2,000,0000.0%0.01%
-10.0%
Q3 2020$1,823,000
+4.5%
2,000,0000.0%0.01%
-16.7%
Q2 2020$1,745,000
+5.1%
2,000,0000.0%0.01%
-14.3%
Q1 2020$1,661,000
-3.7%
2,000,0000.0%0.01%
+16.7%
Q4 2019$1,725,000
+3.9%
2,000,0000.0%0.01%
-7.7%
Q3 2019$1,661,000
-73.5%
2,000,000
-72.7%
0.01%
-74.5%
Q2 2019$6,278,0007,330,0000.05%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 70,062,000$61,167,0007.51%
SYMPHONY ASSET MANAGEMENT LLC 18,000,000$15,668,0005.06%
Context Capital Management, LLC 6,350,000$5,569,0002.17%
CANYON CAPITAL ADVISORS LLC 60,000,000$52,680,0001.76%
Opti Capital Management, LP 8,500$7,400,0001.26%
III Capital Management 5,000,000$4,365,0001.08%
FALCON POINT CAPITAL, LLC 250,000$219,0001.07%
Venator Capital Management Ltd. 1,500,000$1,308,0000.86%
ADVENT CAPITAL MANAGEMENT /DE/ 30,500,000$26,576,0000.62%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 22,500,000$19,733,0000.48%
View complete list of LIGAND PHARMACEUTICALS INC shareholders